Navigation Links
Huifeng Bio-Pharmaceutical Technology, Inc. to Attend 2011 CPhI Frankfurt
Date:10/10/2011

XI'AN, China, Oct. 10, 2011 /PRNewswire-Asia-FirstCall/ -- Huifeng Bio-Pharmaceutical Technology, Inc. (OTC Pink: HFGB) ("Huifeng" or the "Company"), a Xi'an, China-based developer and producer of botanical extracts and other raw materials used in pharmaceuticals and food additives, today announced its subsidiary Shaanxi Huifeng Pharmaceutical Ltd. will attend the CPhI Worldwide Frankfurt 2011 in Germany.

The three-day event will take place from October 25-27 at the Messe Frankfurt exhibition grounds, located at Ludwig-Ernhard-Anlage 1, Frankfurt am Main, Germany, 60327.  Huifeng's booth number will be 31C23 and located in Hall 3.1. Shaanxi Huifeng Pharmaceutical Ltd. has obtained Diosmin COS certificate in May, 2011. In this event, Huifeng plans to showcase its Diosmin and Rutin series products including Rutin NF11, Rutin DAB10, EP7, Troxerutin EP7, Quercetin, Rhamnose.

"We are really looking forward to attending the 2011 CPhI Worldwide Conference," said Huifeng's Founder, Executive Chairman and CEO, Jing'an Wang. "It will be a great opportunity to meet with customers and other businesses from around the globe, and to talk with them about the industry in general and our products' competitive advantages in particular. Attending CPhI's recent exhibition in Shanghai, China was an excellent learning experience for us, and we believe that CPhI's upcoming event in Frankfurt, Germany will provide us with even greater opportunities to enrich our understanding of the current landscape of the pharmaceutical and health care sectors. Moreover, we are thrilled to have the opportunities at the conference to market our flagship products, Rutin series product and Diosmin, and to increase overall customer awareness."

About Huifeng Bio-Pharmaceutical Technology, Inc.Huifeng Bio-Pharmaceutical Technology, Inc. is a Xi'an, China-based Company engaged in the production and supply of high quality plant extracts and raw materials used to produce pharmaceuticals, nutraceuticals and food. Founded in 2000, Huifeng is the leading Chinese producer and exporter of Rutin and Rutin-related plant derived flavonoids, as well as a significant producer of Diosmin. The Company's subsidiary Shaanxi Huifeng Pharmaceutical Ltd. obtained COS Certificate in May, 2011. The Certificate number is R0-CEP 2009-032-Rev 00. Shaanxi Huifeng Pharmaceutical Ltd. is a GMP manufacturer for Rutin and Troxerutin and passed ISO9001:2000 in 2002. Both of these flavonoids are known to have antioxidant and medicinal properties and are used as ingredients in therapies that target venous diseases, inflammation, and dermatitis among other health issues. The Company is currently diversifying its product lines through internal development, acquisition and cooperation with scientific research organizations. For more information about Huifeng Bio-Pharmaceutical Technology, please visit its corporate website at: http://www.hfgb.cn

Safe Harbor StatementThis release contains certain "forward-looking statements" relating to the business of Huifeng Bio-Pharmaceutical Technology, Inc. and its subsidiary companies. These forward-looking statements are often identified by the use of forward-looking terminology such as "believes," "expects" or similar expressions. Such forward-looking statements involve known and unknown risks and uncertainties that may cause actual results to be materially different from those described herein as anticipated, believed, estimated or expected. Investors should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including the risk factors set forth in the Company's annual report on Form 10-K and quarterly reports on Form 10-Q.Company Contact: Mrs. Bing HeHuifeng Bio-Pharmaceutical Technology, Inc.Tel: +86-139-919-54170Fax: +86-29-8825-0444Email: bing@xahuifeng.com
'/>"/>

SOURCE Huifeng Bio-Pharmaceutical Technology, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Huifeng Bio-Pharmaceutical Technology Announces New Senior Vice President of Finance
2. Huifeng Bio-Pharmaceutical Reported Second Quarter 2010 Financial Results and Reaffirms its 2010 Guidance
3. Huifeng Bio-Pharmaceutical Technology Announces a New Spain Order
4. Huifeng Bio-Pharmaceutical Technology Reports 26% Quarterly Revenue Increase
5. HUYA BIOSCIENCE INTERNATIONAL ENGAGES IN PARTNERSHIP WITH LIAONING (BENXI) BIO-PHARMACEUTICAL INDUSTRY BASE
6. Renhuang to Launch New Bio-pharmaceutical Product - Ginseng and Deer Antler Extract
7. Continuous Glucose Monitors: Evolving Technology, Emerging Opportunities
8. FDA Seeks Comment on Streamlined Review of Lower Risk, New Technology, Devices
9. Terumo Corporation, A Global Leader In Medical Device Technology, Celebrates 90th Anniversary
10. Antibody-Drug Conjugates 2011 - real breakthrough still to come. A Technology, Stakeholder and R&D Pipeline Analysis
11. Molecular Devices Releases Breakthrough TUNE Technology, Now Part of the SpectraMax® Paradigm® Multi-Mode Microplate Detection Platform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... Research and Markets has announced the addition of the "Global ... report to their offering. ... The global wound care market was worth $24,482.9 million in 2015 ... 2016-2022 Among the various wound care products type, the advanced ... in 2015. Among the various applications, surgical wound segment held the largest ...
(Date:3/24/2017)... SHANGHAI , March 24, 2017 /PRNewswire/ ... organization providing high-quality and cost-effective drug development ... the pharmaceutical and biotechnology industry, announced today ... ShangPharma will be consolidating the ... Organizations (CMO) under Shanghai ChemPartner. These entities ...
(Date:3/24/2017)... Research and Markets has announced the addition of the ... report to their offering. ... The Deep Learning: Drug Discovery and Diagnostics Market, 2017-2035 ... market of deep learning solutions within the healthcare domain. Primarily driven ... a novel solution to generate relevant insights from medical data. ...
Breaking Medicine Technology:
(Date:3/24/2017)... ... March 24, 2017 , ... Texas Physical Therapy ... be found at 9618 Huebner Road. The clinic is the group’s 7th location in ... and Dr. Ali Higgins, PT, will provide care from the clinic, which opened March ...
(Date:3/24/2017)... ... March 24, 2017 , ... In ... innovative EcoQube Frame vertical micro-veggies garden on Kickstarter . Surpassing the $100,000 ... – with nearly 2,000 consumers (and counting) already backing the campaign. , ...
(Date:3/24/2017)... , ... March 24, 2017 , ... The law firm ... Plains, N.Y., is pleased to announce Westchester resident Lauren C. Enea has joined the ... for the firm, will concentrate her practice in elder law, Medicaid planning and applications, ...
(Date:3/24/2017)... ... 2017 , ... Judy Buchanan, co-owner of Serenity Natural Health ... says, “I am passionate about sharing Reiki as a holistic, complementary therapy with ... time.” , A Certified Medical Reiki™ Master trained by Raven Keys Medical Reiki™ ...
(Date:3/24/2017)... ... March 24, 2017 , ... ... inspiring stories about real people of God in congregations across the United States. ... a Presbyterian minister ordained in 1964 who has served congregations in seven states ...
Breaking Medicine News(10 mins):